A courageous mother from Surrey is leading the charge for research aimed at developing gentler cancer treatments for children and at-risk patients. Hannah Moore, now 28 years old and residing in Guildford, carries with her a remarkable story of survival against acute lymphoblastic leukaemia, a battle she began at the tender age of two and a half.

Hannah fought a grueling health battle through multiple rounds of chemotherapy, regular blood tests, and lumbar punctures. Thankfully, she eventually entered remission but faced a haunting perspective: the treatments she endured posed a risk of infertility later in life.

In a striking testament to resilience, Hannah defied the odds by having three healthy children. She has since become an advocate for Leukaemia UK, a pioneering research charity that dedicates itself to funding innovative cancer research projects. “When I was 18, my last appointment on the children’s ward focused on potential long-term effects, including heart health and the likelihood of having children," Hannah shared. "I was told I would probably experience early menopause.

The plot took a remarkable turn when Hannah met her husband, Carl, at 21. With their hopes high, they started their journey to parenthood. “I felt immense relief when I finally got pregnant,” Hannah recalled. “I would have been devastated if I couldn't have children. Each pregnancy went smoothly, with close monitoring from consulting doctors, but resulted in perfectly healthy babies.”

Today, she is committed to being the best mother she can be, embodying the love and strength she believes is so vital for her children’s futures. Her passion for advocacy shines through, as she dedicates her efforts towards Leukaemia UK, praising the life-saving research they fund.

Leukaemia UK plays a critical role in advancing cancer treatment. Each year, the charity awards significant grants—amounting to £150,000 each—to early-career researchers. Among them is Dr. Yang Li from University College London, who is currently utilizing this funding to explore gentler, yet more effective treatment alternatives for vulnerable patients, especially children and those who have experienced relapses.

The research spearheaded by Dr. Li not only aims to minimize the adverse effects of conventional treatments but also aspires to revolutionize the way childhood cancer is approached, providing hope to countless families grappling with similar challenges. As the landscape of cancer treatment evolves, Hannah Moore stands at the forefront, a survivor and a beacon of hope advocating for a future where kinder treatments are within reach.

Stay tuned as we follow Hannah's inspiring journey and the groundbreaking advancements in cancer research that could change lives forever!